Neutrophils in cancer drug resistance: Roles and therapeutic opportunities
Cancer Letters · 2025
DOI: 10.1016/j.canlet.2024.217417 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Letters, 2025. Verfasst von Hao Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, National Clinical Research Center for Digestive Diseases, Xijing…. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Neutrophils, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 135 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
The tumor microenvironment (TME) is closely associated with the therapeutic response and clinical outcome of cancer drug therapies, which mainly include immunotherapy, chemotherapy and targeted therapy. Neutrophils that infiltrate tumors, also known as tumor-associated neutrophils (TANs), constitute a primary part of the TME. However, the functional importance of TANs in cancer drug therapy has long been overlooked because of their relatively short life span. Recent studies have shown that TANs play crucial protumoral or antitumoral roles in cancer drug treatment, largely because of their diversity and plasticity. This review describes the development, heterogeneity and recruitment of neutrophils in the context of cancer and emphasizes the role and mechanisms of TANs in cancer drug resistance. Additionally, several potential neutrophil-targeted strategies are discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, National Clinical Research Center for Digestive Diseases, Xijing Hospital, Fourth Military Medical University, 710032, Xi'an, Shaanxi,…
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Liu, H., Zhao, H., Zhou, M., Zhao, X., & Lu, Y. (2025). Neutrophils in cancer drug resistance: Roles and therapeutic opportunities. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.217417
Vancouver
Liu H, Zhao H, Zhou M, Zhao X, Lu Y. Neutrophils in cancer drug resistance: Roles and therapeutic opportunities. Cancer Letters. 2025. doi:10.1016/j.canlet.2024.217417
BibTeX
@article{Liu2025,
author = {Liu, Hao and Zhao, Hongyu and Zhou, Mingzhen and Zhao, Xiaodi and Lu, Yuanyuan},
title = {Neutrophils in cancer drug resistance: Roles and therapeutic opportunities},
journal = {Cancer Letters},
year = {2025},
doi = {10.1016/j.canlet.2024.217417}
}
EUVIMED